Skin sympathetic neuroeffector response is attenuated dose-dependently by systemic prostaglandin E1 injection in humans

Satoshi Iwase, Kiyoto Yamamoto, Chihiro Miwa, Atsunori Kamiya, Yuki Niimi, Qi Fu, Tadaaki Mano

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To clarify the effects of prostaglandin E1 (PGE1) on the vasoconstrictive responses, we compared the correlation between the amplitude of integrated skin sympathetic nerve activity (SSNA) and per cent reduction in skin blood flow (SBF) before and after the infusion of lipo PGE1 and placebo (bolus one-shot infusion, single blind study), and constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1 by infusion pump, dose- dependency study) in ten healthy men. SSNA was recorded microneurographically from the median nerve simultaneously with SBF by laser Doppler flowmetry at the index fingertip. The measurement was conducted 30 min after injection of lipo PGE1 or placebo, and during the drip infusion of 10 and 50 ng kg-1 min-1 of PGE1 with maneuvers to enhance SSNA. The resting and activated skin blood flow were not significantly different between 10 ng lipo PGE1 and placebo administration, and between baseline and 10, 50 ng kg-1 min-1 of PGE1 injection. The vascular response, defined as the slope of regression line between logarithm of amplitude of integrated SSNA bursts and the reduction in SBF, was significantly suppressed by injection of lipo PGE1 as compared with that by placebo. It was also decreased dose-dependently by the constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1). We concluded that the intravenous injection of PGE1 attenuates vasoconstrictive responses to SSNA, and analysis of the relations between SSNA and vasoconstrictive response, i.e. the neuroeffector response, is suggested to be an important tool to assess the drug effect. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)191-194
Number of pages4
JournalNeuroscience Letters
Volume292
Issue number3
DOIs
Publication statusPublished - Oct 13 2000
Externally publishedYes

Fingerprint

Alprostadil
Skin
Injections
Placebos
Single-Blind Method
Infusion Pumps
Laser-Doppler Flowmetry
Median Nerve
Intravenous Infusions
Intravenous Injections
Blood Vessels

Keywords

  • Alprostadil
  • Laser Doppler flowmetry
  • Microneurography
  • Skin sympathetic nerve activity
  • Vasoconstrictor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Skin sympathetic neuroeffector response is attenuated dose-dependently by systemic prostaglandin E1 injection in humans. / Iwase, Satoshi; Yamamoto, Kiyoto; Miwa, Chihiro; Kamiya, Atsunori; Niimi, Yuki; Fu, Qi; Mano, Tadaaki.

In: Neuroscience Letters, Vol. 292, No. 3, 13.10.2000, p. 191-194.

Research output: Contribution to journalArticle

Iwase, Satoshi ; Yamamoto, Kiyoto ; Miwa, Chihiro ; Kamiya, Atsunori ; Niimi, Yuki ; Fu, Qi ; Mano, Tadaaki. / Skin sympathetic neuroeffector response is attenuated dose-dependently by systemic prostaglandin E1 injection in humans. In: Neuroscience Letters. 2000 ; Vol. 292, No. 3. pp. 191-194.
@article{4b16d9eb059a4279ab1dc0ac156c8615,
title = "Skin sympathetic neuroeffector response is attenuated dose-dependently by systemic prostaglandin E1 injection in humans",
abstract = "To clarify the effects of prostaglandin E1 (PGE1) on the vasoconstrictive responses, we compared the correlation between the amplitude of integrated skin sympathetic nerve activity (SSNA) and per cent reduction in skin blood flow (SBF) before and after the infusion of lipo PGE1 and placebo (bolus one-shot infusion, single blind study), and constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1 by infusion pump, dose- dependency study) in ten healthy men. SSNA was recorded microneurographically from the median nerve simultaneously with SBF by laser Doppler flowmetry at the index fingertip. The measurement was conducted 30 min after injection of lipo PGE1 or placebo, and during the drip infusion of 10 and 50 ng kg-1 min-1 of PGE1 with maneuvers to enhance SSNA. The resting and activated skin blood flow were not significantly different between 10 ng lipo PGE1 and placebo administration, and between baseline and 10, 50 ng kg-1 min-1 of PGE1 injection. The vascular response, defined as the slope of regression line between logarithm of amplitude of integrated SSNA bursts and the reduction in SBF, was significantly suppressed by injection of lipo PGE1 as compared with that by placebo. It was also decreased dose-dependently by the constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1). We concluded that the intravenous injection of PGE1 attenuates vasoconstrictive responses to SSNA, and analysis of the relations between SSNA and vasoconstrictive response, i.e. the neuroeffector response, is suggested to be an important tool to assess the drug effect. (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "Alprostadil, Laser Doppler flowmetry, Microneurography, Skin sympathetic nerve activity, Vasoconstrictor",
author = "Satoshi Iwase and Kiyoto Yamamoto and Chihiro Miwa and Atsunori Kamiya and Yuki Niimi and Qi Fu and Tadaaki Mano",
year = "2000",
month = "10",
day = "13",
doi = "10.1016/S0304-3940(00)01463-4",
language = "English",
volume = "292",
pages = "191--194",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Skin sympathetic neuroeffector response is attenuated dose-dependently by systemic prostaglandin E1 injection in humans

AU - Iwase, Satoshi

AU - Yamamoto, Kiyoto

AU - Miwa, Chihiro

AU - Kamiya, Atsunori

AU - Niimi, Yuki

AU - Fu, Qi

AU - Mano, Tadaaki

PY - 2000/10/13

Y1 - 2000/10/13

N2 - To clarify the effects of prostaglandin E1 (PGE1) on the vasoconstrictive responses, we compared the correlation between the amplitude of integrated skin sympathetic nerve activity (SSNA) and per cent reduction in skin blood flow (SBF) before and after the infusion of lipo PGE1 and placebo (bolus one-shot infusion, single blind study), and constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1 by infusion pump, dose- dependency study) in ten healthy men. SSNA was recorded microneurographically from the median nerve simultaneously with SBF by laser Doppler flowmetry at the index fingertip. The measurement was conducted 30 min after injection of lipo PGE1 or placebo, and during the drip infusion of 10 and 50 ng kg-1 min-1 of PGE1 with maneuvers to enhance SSNA. The resting and activated skin blood flow were not significantly different between 10 ng lipo PGE1 and placebo administration, and between baseline and 10, 50 ng kg-1 min-1 of PGE1 injection. The vascular response, defined as the slope of regression line between logarithm of amplitude of integrated SSNA bursts and the reduction in SBF, was significantly suppressed by injection of lipo PGE1 as compared with that by placebo. It was also decreased dose-dependently by the constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1). We concluded that the intravenous injection of PGE1 attenuates vasoconstrictive responses to SSNA, and analysis of the relations between SSNA and vasoconstrictive response, i.e. the neuroeffector response, is suggested to be an important tool to assess the drug effect. (C) 2000 Elsevier Science Ireland Ltd.

AB - To clarify the effects of prostaglandin E1 (PGE1) on the vasoconstrictive responses, we compared the correlation between the amplitude of integrated skin sympathetic nerve activity (SSNA) and per cent reduction in skin blood flow (SBF) before and after the infusion of lipo PGE1 and placebo (bolus one-shot infusion, single blind study), and constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1 by infusion pump, dose- dependency study) in ten healthy men. SSNA was recorded microneurographically from the median nerve simultaneously with SBF by laser Doppler flowmetry at the index fingertip. The measurement was conducted 30 min after injection of lipo PGE1 or placebo, and during the drip infusion of 10 and 50 ng kg-1 min-1 of PGE1 with maneuvers to enhance SSNA. The resting and activated skin blood flow were not significantly different between 10 ng lipo PGE1 and placebo administration, and between baseline and 10, 50 ng kg-1 min-1 of PGE1 injection. The vascular response, defined as the slope of regression line between logarithm of amplitude of integrated SSNA bursts and the reduction in SBF, was significantly suppressed by injection of lipo PGE1 as compared with that by placebo. It was also decreased dose-dependently by the constant rate infusion of PGE1 (10 and 50 ng kg-1 min-1). We concluded that the intravenous injection of PGE1 attenuates vasoconstrictive responses to SSNA, and analysis of the relations between SSNA and vasoconstrictive response, i.e. the neuroeffector response, is suggested to be an important tool to assess the drug effect. (C) 2000 Elsevier Science Ireland Ltd.

KW - Alprostadil

KW - Laser Doppler flowmetry

KW - Microneurography

KW - Skin sympathetic nerve activity

KW - Vasoconstrictor

UR - http://www.scopus.com/inward/record.url?scp=0034644954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034644954&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(00)01463-4

DO - 10.1016/S0304-3940(00)01463-4

M3 - Article

C2 - 11018309

AN - SCOPUS:0034644954

VL - 292

SP - 191

EP - 194

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -